Covaxin gets SEC approval: Getting the experts’ perspective https://ift.tt/eA8V8J

If granted approval by DCGI, Covaxin will become only the second vaccine after Zydus Cadila's ZyCoV-D to be granted permission for inoculating children in 2-18 age group.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/308wCQP
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.